StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) stock

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$61.43+2.92 (+4.99%)

Close on Nov 18, 2026Market cap $11.89BP/E 161.7Yield –

BioMarin Pharmaceutical market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioMarin Pharmaceutical's market cap was $11.29B on Nov 11, 2026, against $10.74B a year earlier. Over the last 5 years it ranged from $10.29B to $21.43B, with a median of $14.37B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.29B-1.1%
2025Dec 31, 2025$11.42B-8.9%
2024Dec 31, 2024$12.53B-31.0%
2023Dec 29, 2023$18.16B-5.6%
2022Dec 30, 2022$19.23B+18.6%
2021Dec 31, 2021$16.22B+1.9%
2020Dec 31, 2020$15.92B+4.8%
2019Dec 31, 2019$15.19B+0.2%
2018Dec 31, 2018$15.15B-3.2%
2017Dec 29, 2017$15.65B+10.0%
2016Dec 30, 2016$14.22B-15.8%
2015Dec 31, 2015$16.89B+26.7%
2014Dec 31, 2014$13.33B+33.2%
2013Dec 31, 2013$10.00B+64.3%
2012Dec 31, 2012$6.09B+55.2%
2011Dec 30, 2011$3.92B+42.2%
2010Dec 31, 2010$2.76B+41.6%
2009Dec 31, 2009$1.95B–

More BioMarin Pharmaceutical figures

See a number that looks wrong?